Butantan starts producing Brazilian vaccine

The Butantan Institute started Wednesday to produce Butanvac, the Brazilian vaccine against Covid-19. The immunizer still needs to be approved by Brazilian Health Regulatory Agency (Anvisa). According to Dimas Covas, director of the institute, 15 million to 18 million doses will be manufactured by June. The production capacity can reach 150 million jabs, if necessary, he said. The technology of the vaccine is similar to the flu vaccine and there is no need to import inputs for its production. Butantan filed a request for phase 1 and 2 tests with volunteers, but Anvisa Tuesday asked for more information from the laboratory. In another development, Brazil is going to receive this Thursday 1 million doses of the Pfizer/BioNTech vaccine, refused for months by the federal government. An agreement has been made and the arrival of the shots has been unlocked.

Source: Valor international

https://www.valor.com.br/international/briefs